Zealand Pharma A/S (LON:0NZU)

Zealand Pharma Ratios and Metrics

Market cap in millions GBP. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Oct 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	4,244	5,605	2,536	1,236	708	1,055
Market Cap Growth	-31.96%	120.99%	105.19%	74.51%	-32.87%	9.83%
Enterprise Value	2,341	4,628	2,366	1,254	606	887
Last Close Price	59.99	79.79	44.01	24.39	16.30	26.67
PE Ratio	5.53	-	-	-	-	-
PS Ratio	4.05	806.30	63.55	99.69	57.77	45.65
PB Ratio	2.37	5.87	13.68	12.71	6.76	7.13
P/TBV Ratio	2.37	5.88	13.78	12.71	7.17	7.48
P/FCF Ratio	4.91	-	-	-	-	-
P/OCF Ratio	4.90	-	-	-	-	-
EV/Sales Ratio	2.19	665.70	59.28	101.16	49.41	38.39
EV/FCF Ratio	2.71	-	-	-	-	-
Debt / Equity Ratio	0.03	0.05	0.08	0.64	0.85	0.11
Debt / FCF Ratio	0.05	-	-	-	-	-
Asset Turnover	0.67	0.01	0.20	0.06	0.06	0.11
Inventory Turnover	-	0.85	0.69	-	0.12	-
Quick Ratio	15.08	21.11	6.23	6.73	4.80	3.71
Current Ratio	15.09	21.14	6.25	6.73	5.15	4.00
Return on Equity (ROE)	53.44%	-21.13%	-58.43%	-110.75%	-69.99%	-54.10%
Return on Assets (ROA)	32.86%	-13.81%	-19.93%	-28.30%	-25.53%	-23.29%
Return on Capital (ROIC)	34.83%	-14.80%	-22.99%	-33.41%	-31.80%	-29.12%
Earnings Yield	18.09%	-2.13%	-3.23%	-11.60%	-16.24%	-9.66%
FCF Yield	20.38%	-1.86%	-2.01%	-9.20%	-19.68%	-8.14%
Buyback Yield / Dilution	-18.37%	-17.40%	-22.49%	-7.77%	-11.73%	-13.51%

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.